María del Carmen Bangher

Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic  T. Cruzi Carriers

Carlos A. Morillo, Hetty Waskin, Sergio Sosa‐Estáni et al. · Journal of the American College of Cardiology · 2017 · 315 citations · Full text

Veterinary Medicine, Biology, Infectious Diseases +12

Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial

Julio Vallejos, Rodrigo Zoni, María del Carmen Bangher et al. · BMC Infectious Diseases · 2021 · 118 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +14

Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II superiority clinical trial

Daniel Molina‐Morant, Marisa Fernández, Pau Bosch‐Nicolau et al. · Trials · 2020 · 62 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial

Pau Bosch‐Nicolau, Marisa Fernández, Elena Sulleiro et al. · The Lancet Infectious Diseases · 2024 · 42 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +5

Deep Dive Into Gaps and Barriers to Implementation of Antimicrobial Stewardship Programs in Hospitals in Latin America

Valeria Fabre, Clara Secaira, Sara E. Cosgrove et al. · Clinical Infectious Diseases · 2023 · 37 citations · Full text

Pharmacy, Health Policy, Health Services Administration +14